409 filings
Page 5 of 21
425
u75j8hj64i 1jl
23 Jul 21
Business combination disclosure
8:41am
8-K
7da2degsvrn4i0lv1psd
21 Jul 21
Other Events
5:17pm
425
wncw9dpgs wja2nx5
21 Jul 21
Business combination disclosure
5:15pm
EFFECT
ujoukdpz7pb
16 Jul 21
Notice of effectiveness
12:15am
424B3
nnmgdwv3onc59dt256
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
576ny7rmthswr9e
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
CORRESP
d0w57
13 Jul 21
Correspondence with SEC
12:00am
UPLOAD
tyho9d05
6 Jul 21
Letter from SEC
12:00am
S-4
0ctfh81zbd9e0e8ivzmx
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
p9ymg1yi5 wza66bfn1j
22 Jun 21
Acasti Pharma Provides Fiscal 2021 Year-End Business Update
7:00am
8-K
2iliqq bq
17 May 21
Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
7:11am
8-K
tngjcilpjld
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
mquq6ia3d
7 May 21
Business combination disclosure
7:08am
8-K
ww9uhz
9 Mar 21
Acasti Pharma Provides Update on Recent Financing Activities
12:00am
8-K
2wj3imy qwx8xxmhd
9 Feb 21
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
4:35pm
8-K
qk7ucug oo
27 Jan 21
Acasti Pharma Provides Update on Recent Financing Activities
7:35am
8-K
6t55z
4 Dec 20
Other Events
8:00am
8-K
zglqhw
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am